The regulatory role of nitric oxide (NO) in vaginal perfusion remains unclear. We used specific inhibitors of enzymes in the NO-cyclic GMP (NO-cGMP) pathway and investigated their effects on vaginal blood flow in the rabbit. NO synthase (NOS) activity was similar in both the proximal and distal rabbit vagina; whereas, arginase activity was 3.4-fold higher in the distal vagina. Intravenous administration of the NOS inhibitor L-NAME resulted in a 66% reduction in genital tissue oxyhemoglobin and a 53% reduction in vaginal blood flow. This attenuation occurred despite a 20-30% increase in systemic arterial pressure. The arginase inhibitor ABH caused a 2.1-fold increase in genital tissue oxyhemoglobin and 34% increase in vaginal blood flow. The guanylate cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one and the phosphodiesterase type 5 inhibitor sildenafil caused in a 37% reduction and a 44% increase in vaginal blood flow, respectively. These observations suggest that the NO-cGMP pathway is an important regulator of vaginal hemodynamics.
Introduction
The arousal phase of the female sexual response involves, in part, local regulatory mechanisms that modulate tone in the clitoral and labial erectile tissue and the vascular and nonvascular smooth muscle of the vagina. 1, 2 Immunohistochemical studies in human vaginal tissues have identified nerve fibers containing neuropeptide Y, vasoactive intestinal polypeptide (VIP), nitric oxide synthase (NOS), calcitonin gene-related peptide and substance P. 3 Previous studies have suggested that VIP may be involved in the regulation of clitoral and vaginal smooth muscle tone, but no conclusive experimental evidence of its functional involvement has been forthcoming. [3] [4] [5] [6] [7] [8] Cellek and Moncada 9 demonstrated that electrical field stimulation causes nonadrenergic, noncholinergic (NANC) relaxation responses that are mediated by nitric oxide (NO) in rabbit clitoral corpus cavernosum. While the NO-cyclic GMP (NOcGMP) pathway has been reported to be the major mediator of neurogenic relaxation in rat vagina, 10 its significance in the rabbit has been questioned. 11 However, these prior studies only investigated nonvascular smooth muscle relaxation in organ baths and did not examine the reactivity of blood vessels within the vagina. To fully appreciate the role of the NO-cGMP pathway in the vagina, the regulation of vascular smooth muscle tone must also be studied.
Thus, the goal of this study was to investigate the role of NO in regulating vaginal blood flow in vivo. To this end, experiments were performed in anesthetized female rabbits using inhibitors of NOS, arginase, guanylate cyclase and phosphodiesterase type 5 (PDE 5); enzymes that modulate the NO-cGMP pathway. We also measured the enzymatic activities of NOS and arginase in the vagina. Arginase catalyzes the conversion of L-arginine to ornithine and urea, while NOS utilizes L-arginine as a cosubstrate in the production of NO. Studies in other tissues have demonstrated the ability of arginase to decrease arginine availability for NOS, thereby decreasing NO production and smooth muscle relaxation.
Methods

Animals
All studies were approved by the Institutional Animal Care and Use Committee at Boston University School of Medicine. Female New Zealand White rabbits (4.0-4.5 kg) were anesthetized with intramuscular injections of ketamine (35 mg/kg) and xylazine (5 mg/kg). For in vivo studies, anesthesia was maintained with intravenous 50 mg/ml sodium nembutal (0.2 ml PRN). For tissue collection, animals were euthanized with 60 mg/kg of sodium nembutal. Vaginal tissue was removed, separated into proximal and distal portions and frozen in liquid nitrogen for enzyme assays.
Preparation of vaginal tissue extracts
Frozen vaginal tissues were pulverized and the resulting tissue powder was homogenized (1 g/3 ml) in ice-cold 20 mM HEPES (pH 7.20) containing 250 mM sucrose, 1 mM EDTA and protease inhibitor cocktail (1 mM AEBSF, 0.8 mM aprotinin, 20 mM leupeptin, 40 mM bestatin, 15 mM pepstatin A and 14 mM E-64; catalog #P8340; Sigma, St Louis, MO, USA). The total cell extract was centrifuged at 1000 g for 30 min at 41C. The supernatant was removed and either used immediately or stored frozen at À751C until experimentation.
Determination of NOS activity
NOS activity in the total tissue extract was determined by conversion of L- [2, H]arginine (NEN Life Science Products, Boston, MA, USA) to [ 3 H]citrulline and NO, as previously described.
14 Briefly, aliquots of the tissue extract were incubated with tetrahydrobiopterin (3 mM), calmodulin (30 U/ml), Larginine (50 mM), L-[ 3 H]arginine (2 mCi/ml), NADPH (20 mM) and CaCl 2 (1 mM) at 371C for 45 min. Parallel samples were incubated at 21C to determine nonspecific activity. Citrulline was separated from arginine by passing samples through 1 ml columns of AG50W-X8 resin (Bio-Rad Laboratories, Hercules, CA, USA) and quantified by scintillation spectroscopy. Citrulline production was normalized to total soluble protein in the tissue.
Determination of arginase activity
Crude tissue extracts were derived from homogenates of rabbit vaginal tissue. Arginase enzyme activity in cytosolic extracts of vaginal tissue was assessed by the method of Rü egg and Russell as previously described. 13 Briefly, tissue extract aliquots (10 ml) in triplicate were incubated in buffer (75 mM glycine, pH 9.0, 0.25 mM MnCl 2 ) containing 300 000 dpm of [ 14 C-guanidino]L-arginine (51.5 mCi/ mmol; NEN Life Science Products, Boston, MA, USA), 4 mM of unlabelled L-arginine in a final volume of 100 ml. Samples were incubated for 60 min at 371C and reactions were terminated by the addition of 400 ml of 0.25 M acetic acid (pH 4.5), 7 M urea, 10 mM L-arginine. After the addition of 500 ml of water, samples were passed through a 0.5 ml column of Dowex 50W-X8 resin (Bio-Rad Laboratories, Hercules, CA, USA). Tubes were rinsed twice with 500 ml of water and both rinses were loaded onto the columns. Columns were washed with 1 ml of water and all effluent was collected in 20 ml vials. After the addition of 16 ml of Liquiscint (National Diagnostics, Atlanta, GA, USA), radioactivity was quantified by liquid scintillation spectroscopy. Urea production was normalized to total soluble protein in the tissue.
Pelvic nerve stimulation
Anesthetized rabbits were secured in the supine position and a 3 cm midline neck incision was fashioned to access the carotid artery. A 20-guage angiocatheter was inserted into the carotid artery and connected to a PT300 pressure transducer (Grass Instruments/Astro-Med, Inc., Warwick, RI, USA) to monitor systemic blood pressure continuously. A 4 cm lower midline abdominal incision was fashioned to expose the pelvic nerve. A bipolar platinum wire electrode was carefully positioned on the isolated pelvic nerve to avoid nerve injury. Unilateral pelvic nerve stimulation (PNS) was accomplished with a Grass S9 stimulator set at normal polarity and repeat mode to generate a 30 s train of square waves with 10 V pulse amplitude and 0.8 msec pulse duration. For each animal, a stimulation frequency causing submaximal response was selected as the lowest frequency that demonstrated two consecutive reproducible control responses. Based on our previous experience, stimulation frequencies below 8 Hz result in submaximal responses and 2 or 4 Hz stimulations were typically adequate. Hemodynamic parameters were continuously recorded throughout the experiment.
Genital blood flow
A dual channel laser oximeter (Model 96208; ISS, Inc., Champaign, IL, USA) was utilized to measure genital blood flow, as described previously. 15 The skin NO-cGMP in regulation of vaginal blood flow SW Kim et al around the labia was carefully shaved to ensure good contact with the optical fibers. The probe was positioned longitudinally, externally over the clitoris, labia and lower vagina such that the detector fiber was positioned just below the pubic arch.
Changes in blood flow were detected as changes in the concentration of oxyhemoglobin.
Vaginal blood flow
Vaginal blood flow was assessed by laser Doppler flowmetry (Model BLF21D, Transonic System Inc, Ithaca, NY, USA). A laser Doppler surface probe (length 14 mm, width 6 mm, height 3 mm) was placed directly in the vaginal canal. The probe was faced toward the lateral or posterior vaginal wall. The data were expressed in tissue perfusion units.
In vivo study protocol
Responses to PNS were measured using either oximetry (for genital blood flow) or laser Doppler flowmetry (for vaginal blood flow). Control responses to PNS were determined in each animal. Vehicle (40% propylene glycol or DMSO) was administered intravenously and PNS was repeated after 10 min. Upon return to baseline values, animals then received intravenous administration of 60 mg/kg of the NOS inhibitor N G -nitro-L-arginine methyl ester (L-NAME) in saline, 6 mg/kg of the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH) in 40% propylene glycol, 1 mg/kg of the guanylate cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one (ODQ) in DMSO or 0.2 mg/kg of the PDE 5 inhibitor sildenafil citrate in saline. PNS was repeated 10 min after administration of a given enzyme inhibitor.
Data analysis
For all laser oximetry and Doppler flowmetry recordings, the area under the curve (AUC) for each response was determined using Microsoft Excel or Windaq (Dataq Instruments, Akron, OH, USA) software. All in vivo responses obtained in the presence of each enzyme inhibitor were transformed as percent of control and the results were expressed as mean7s.d. (n ¼ 5, unless otherwise specified). Data were analyzed by the paired t-test or one-way ANOVA followed by the TukeyKramer post hoc test. Means were considered to be significantly different for P-values less than or equal to 0.05.
Results
Biochemical studies
Activity for NOS and arginase was detected in both the proximal and distal vagina. As shown in Figure 1a , citrulline production, indicative of NOS activity, was not significantly different in the proximal vagina (513.27153.7 pmol/mg prot.) compared to the distal vagina (360.5782.4 pmol/mg prot.). On the other hand, arginase activity (Figure 1b Also, baseline values of genital oxyhemoglobin and vaginal blood flow did not vary significantly after intravenous injection of L-NAME, ABH, ODQ or sildenafil at the doses administered in this study. L-NAME significantly suppressed responses to PNS by 66.3% for genital oxyhemoglobin and by 52.8% for vaginal blood flow 10 min after administration ( Figure 2 ). As shown in Figure 3 , ABH administration increased PNS-induced changes in genital tissue oxyhemoglobin and vaginal blood flow. However, the increase in oxyhemoglobin did not reach statistical significance when compared to control or vehicle (P ¼ 0.07), whereas the increase in vaginal blood flow was statistically significant (Po0.05).
ABH administration had no discernible effect on systemic arterial blood pressure (data not shown). However, intravenous injection of L-NAME caused an increase in mean arterial blood pressure. As shown in Figure 4 , the mean arterial blood pressure 10 min after L-NAME injection (81.677.8 mmHg) was significantly higher (Po0.05) than baseline (59.677.6 mmHg). The increase in blood pressure caused by L-NAME was rapid in onset, reaching a plateau within 5-10 min and was sustained for more than 1 h after administration. The effects of ODQ and sildenafil were only assessed by laser Doppler flowmetry. Intravenous administration of the guanylate cyclase inhibitor ODQ ( Figure 5 ) significantly inhibited PNS-induced vaginal blood flow by 36%, while systemic administration of sildenafil ( Figure 6 ) significantly enhanced PNS-induced vaginal blood flow by 44%. Intravenous administration of ODQ showed no effect on systemic arterial blood pressure. On the other hand, intravenous injection of sildenafil caused a mild, transient drop in systemic blood pressure, which recovered to baseline values within 10 min of the injection at which time PNS was repeated.
Discussion
The importance of the NO-cGMP pathway in mediating neurogenic relaxation of clitoral cavernosal smooth muscle has been demonstrated. 9, 16 In contrast, the role of this pathway in the vagina has only been partially investigated. Using tissue strips in organ bath preparations, Ziessen et al 11 characterized NANC neurogenic relaxation of the rabbit vaginal muscularis (nonvascular smooth muscle). In this study, Ziessen et al observed that the degree of inhibition attained with L-NAME (an NOS inhibitor) or ODQ (guanylate cyclase inhibitor) was no greater than 30%, suggesting that a non-nitrergic component is the major mediator of NANC relaxation response in the rabbit vagina. Interestingly, this nonnitrergic NANC response was not associated with any known neuropeptides or purines and the main relaxatory neurotransmitter remains unidentified. 11 On the other hand, in a separate study using rat distal vaginal tissue, Giraldi et al 10 completely inhibited NANC relaxation using inhibitors of the NO-cGMP pathway. Thus, the NO-cGMP pathway NO-cGMP in regulation of vaginal blood flow SW Kim et al appears to exert differential regulation of smooth muscle function throughout the female genital tract and its predominance in the vagina may be speciesspecific.
To date, there have been no functional studies examining the role of NO in regulating vaginal blood flow. In our study, the inhibition of NOS activity in vivo by L-NAME resulted in a significant reduction in genital tissue oxyhemoglobin and vaginal blood flow. Further, the guanylate cyclase inhibitor ODQ significantly reduced PNS-induced vaginal blood flow, while sildenafil increased vaginal blood flow. These findings are consistent with our previous studies on the facilitating effects of sildenafil on sexual arousal response measured by oximetry, vaginal luminal pressure and vaginal lubrication. 15 The inhibitory effect of L-NAME was somewhat greater when assessed by genital tissue oxyhemoglobin (66.3% inhibition) than vaginal blood flow (52.8% inhibition). Although this difference was not statistically significant, the difference in mean percent inhibition may be due to the fact that laser oximetry measures oxyhemoglobin concentration in both vaginal and clitoral tissues, whereas laser Doppler flowmetry measures blood flow only in the vagina. The inhibition of vaginal blood flow occurred in spite of the rise in mean arterial blood pressure after L-NAME administration. This rise in systemic blood pressure is consistent with other studies that have investigated the role of NOS inhibitors on the regulation of blood pressure and is most likely due to the inhibition of NOS in the endothelium of the resistance arteries. 17, 18 The inhibition of arginase activity by ABH caused an enhancement of genital and vaginal blood flow. These effects of ABH might be due to an increase in the availability of substrate for NOS similar to that seen in penile corpus cavernosum. 12, 13 On average, the effect of ABH was greater on genital tissue oxyhemoglobin than on vaginal blood flow. As mentioned above, this discrepancy may be due to differences between the two techniques. It is interesting to note that arginase enzyme activity was greater in the distal vagina than in the proximal vagina, while the distribution of NOS was similar throughout the vagina. Although we did not characterize which enzyme subtypes were present and did not examine the cellular distribution of NOS and arginase in the rabbit vagina, recent studies by Giraldi et al 10 demonstrated NOS immunoreactivity in plexuses of nerve terminals surrounding vaginal arteries, as well as in a localized region of circular smooth muscle of the distal rat vagina. In future studies, it may be important to investigate regional variations in vaginal blood flow.
The role of arginase in genital tissues has not been well defined. Demonstration of its functional significance has been limited to its inhibitory effect on NO-mediated relaxation in penile corpus cavernosum. 12, 13 This has been attributed to lowering of intracellular arginine stores by arginase. However, this indirect mechanism of NOS regulation may have other consequences in terms of host defense responses. 19, 20 In other tissues, arginase (via arginine metabolism) has been shown to participate in inflammation and wound healing. 20 In addition, arginase can regulate the biosynthesis of polyamines, which are critical for cell growth and proliferation. 20 The presence of higher arginase activity in the distal vagina may be important for some or all of these processes in addition to regulation of smooth muscle tone. Nevertheless, the presence of both NOS and arginase within the same tissue in conjunction with our hemodynamic data suggest that these two enzymes may regulate the production of NO in the vagina in a reciprocal fashion.
Another consideration regarding the differential distribution of enzymes is that the vagina is derived from different embryological structures during development. The distal third of the human vagina is derived from the urogenital sinus and the proximal two thirds from fused mullerian ducts. Moreover, an immunohistochemical study of normal human vaginal tissues demonstrated more nerve fibers in the distal vagina compared to the proximal vagina. 21 Therefore, differences in enzyme distribution between the proximal and distal portions of the vagina may be reflective of differences in development as well as differences in function.
Future in vivo studies investigating hemodynamic regulation in vaginal tissue will need to consider the most appropriate method to quantify engorgement responses, as well as the potential differences between the proximal and distal regions of the vagina. We quantified the effects of each inhibitor by comparison of the AUC for each response, as opposed to comparing peak responses. While oximetry can provide more stable recordings, measurement of peak responses for laser Doppler flowmetry is problematic for several reasons. Using laser Doppler flowmetry, recordings of flow rate in the vagina during pelvic nerve stimulation exhibit an immediate increase with sometimes rapid fluctuations. Since some of these fluctuations are due to transient vaginal contractions, it is difficult to accurately determine the true peak blood flow during the stimulation period. In addition, peak blood flows that occur for only a short duration provide little information regarding the overall quality of the engorgement response. Lastly, the rate of flow can only increase to a finite level that is determined by the arterial-venous pressure gradient. In contrast, AUC reflects a measure of perfusion integrated over time and consequently incorporates 'duration of response' data. Thus, AUC may be a better parameter to measure the overall engorgement response in the vagina. This is consistent with the known mechanism of vaginal engorgement. While there may be partial vasoconstriction in the veins NO-cGMP in regulation of vaginal blood flow SW Kim et al during arousal, there is no veno-occlusive mechanism in the vagina. Thus, engorgement is achieved by a sustained period of increased arterial flow that overcomes venous drainage. This assumption necessitates the inclusion of the time dimension in measuring vaginal engorgement.
In conclusion, our results demonstrate that inhibition of individual enzymes in the NO-cGMP pathway results in consistent and significant alterations in vaginal hemodynamics and suggest that this pathway is an important regulatory mechanism of vaginal blood flow during sexual arousal. Further, we report the first in vivo evidence of a physiological role for arginase in the regulation of NO production within the vagina.
